Bont, L, et al.
RSV – still more questions than answers. Pediatric Infectious Disease Journal
Nair, H, et al.
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet
2010; 375: 1545–1555.
Welliver, RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. Journal of Pediatrics
2003; 143 (5 Suppl.): S112–117.
Hall, CB, et al.
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics
2013; 132: e341–348.
Haynes, LM. Progress and challenges in RSV prophylaxis and vaccine development. Journal of Infectious Diseases
2013; 208 (Suppl. 3): S177–183.
Anderson, LJ. Respiratory syncytial virus vaccine development. Seminars in Immunology
2013; 25: 160–171.
Lloyd, PC, et al.
The effect of birth month on the risk of respiratory syncytial virus hospitalization in the first year of life in the United States. Pediatric Infectious Disease Journal
2014; 33: e135–140.
Houben, ML, et al.
Clinical prediction rule for RSV bronchiolitis in healthy newborns: prognostic birth cohort study. Pediatrics
2011; 127: 35–41.
Holberg, CJ, et al.
Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life. American Journal of Epidemiology
1991; 133: 1135–1151.
Figueras-Aloy, J, et al.
FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatric Infectious Disease Journal
2008; 27: 788–793.
Cilla, G, et al.
Risk factors for hospitalization due to respiratory syncytial virus infection among infants in the Basque Country, Spain. Epidemiology and Infection
2006; 134: 506–513.
Murray, J, et al.
Risk factors for hospital admission with RSV bronchiolitis in England: a population-based birth cohort study. PLoS ONE
2014; 9: e89186.
Müller-Pebody, B, et al.
Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998. Epidemiology and Infection
2002; 129: 99–106.
Pitman, RJ, et al.
Assessing the burden of influenza and other respiratory infections in England and Wales. Journal of Infection
2007; 54: 530–538.
Cromer, D, et al.
The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. Journal of Infection
2014; 68: 363–371.
Zhao, H, et al.
A new laboratory-based surveillance system (Respiratory DataMart System) for influenza and other respiratory viruses in England: results and experience from 2009 to 2012. Eurosurveillance
McGuiness, CB, et al.
Respiratory syncytial virus surveillance in the United States, 2007–2012: results from a national surveillance system. Pediatric Infectious Disease Journal
2014; 33: 589–594.
Mullins, JA, et al.
Substantial variability in community respiratory syncytial virus season timing. Pediatric Infectious Disease Journal
2003; 22: 857–862.
Thornton, H V, et al.
Clinical presentation and microbiological diagnosis in paediatric respiratory tract infection: a systematic review. British Journal of General Practice
2015; 65: e69–81.
Moore, HC, et al.
Use of data linkage to investigate the aetiology of acute lower respiratory infection hospitalisations in children. Journal of Paediatrics and Child Health
2012; 48: 520–528.
Sommer, C. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiology Journal
2011; 5: 144–154.
Alvarez, AE, et al.
Epidemiological and genetic characteristics associated with the severity of acute viral bronchiolitis by respiratory syncytial virus. Jornal de Pediatria (Rio de Janeiro)
2013; 89: 531–543.
Anderson, LJ, et al.
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine
2013; 31 (Suppl. 2): B209–215.
Modjarrad, K, et al.
WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization Meeting held on 23–24 March 2015. Vaccine
2016; 34: 190–197.
Mytton, OT, Rutter, PD, Donaldson, LJ. Influenza A(H1N1)pdm09 in England, 2009 to 2011: a greater burden of severe illness in the year after the pandemic than in the pandemic year. European Centre for Disease Prevention and Control (ECDC) – Health Comunication Unit, 2012.